The price of dialysis access: Implications of access type and patient-centric approaches to cost
Patient OOP costs and provider reimbursement differ significantly based on procedure, insurance type, and service site. While pAVF creation is recognized with high reimbursements due to its complexity and the advanced technology required, it also has the highest OOP costs for patients. To help facilitate adoption of new technologies like pAVF, advocacy efforts should focus on encouraging payers to lower the OOP financial barriers for patients to receive these newer but costlier procedures.
Authors
- Janice Newsome (ORCID: https://orcid.org/0000-0002-2472-3815)
- Menelaos Konstantinidis (ORCID: https://orcid.org/0000-0002-5074-9023)
- Brian Byun (ORCID: https://orcid.org/0009-0001-2257-4983)
- Victoria Teodorescu
- Deepak Iyer (ORCID: https://orcid.org/0000-0002-4446-0012)
- John T. Moon (ORCID: https://orcid.org/0000-0003-3110-9060)
- Zachary Bercu (ORCID: https://orcid.org/0000-0003-1307-3770)
- Hanzhou Li (ORCID: https://orcid.org/0000-0003-1614-5717)
- Nathan Sim (ORCID: https://orcid.org/0009-0009-0118-9769)
- A. Bikmal
Institutions
- St. Michael's Hospital (CA)
- Emory University (US)
- Virginia Commonwealth University (US)
- University of Toronto (CA)
- Wayne State University (US)
- George Washington University (US)
- Unity Health Toronto
Publication Details
- Journal
- The Journal of Vascular Access
- Published
- 2024-11-07
- DOI
- https://doi.org/10.1177/11297298241290548
- Primary Topic
- Central Venous Catheters and Hemodialysis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Harvey L. Neiman Health Policy Institute